Deals
Horizon Therapeutics Said Near Deal to Buy Nitec
This article is for subscribers only.
Horizon Therapeutics Inc., a U.S. developer of pain medications, is close to an agreement to buy Switzerland’s Nitec Pharma AG, said a person with knowledge of the transaction.
The combined company will be based at Horizon’s headquarters in Northbrook, Illinois, said the person, who declined to be identified because the talks are private. Executives of Nitec, which was spun off from Darmstadt, Germany- based Merck KGaA in 2004, and Horizon declined to comment.